A...
Childhood Trauma and Mental Health: A Systems Biology Approach to Treatment-Resistant Anxiety and OCD
Childhood adversity may leave lasting physiological effects that extend beyond psychological symptoms. Through a case of a 19-year-old woman with persistent anxiety, OCD, emotional eating, and hyperandrogenic metabolic dysfunction, this article examines how neuroendocrine, metabolic, immune, nutritional, and gut-brain pathways may interact—and how a systems biology approach can complement conventional psychiatric care.
Christopher Magryta, MD
Key points
- Childhood trauma may become biologically embedded across multiple physiological systems. Prolonged early-life adversity and accumulated allostatic load may alter HPA-axis signaling, insulin sensitivity, reproductive hormones, immune regulation, and gut-brain communication. These adaptations, though initially protective during periods of stress, can become maladaptive and contribute to persistent psychiatric and metabolic symptoms.
- Treatment-resistant psychiatric symptoms may reflect interconnected physiological disturbances rather than isolated neurotransmitter dysfunction. In this case, a 19-year-old woman with anxiety, OCD, panic attacks, emotional eating, and hyperandrogenic PCMOS demonstrated findings involving elevated cortisol activity, androgen excess, reduced short-chain fatty acid production, nutritional insufficiencies, and an elevated systemic immune-inflammation index.
- Restoring physiological resilience requires addressing multiple systems while continuing psychiatric treatment. The therapeutic strategy combined an anti-inflammatory dietary pattern, metabolic and endocrine support, correction of nutritional deficiencies, gut microbiome interventions, physical activity, sleep optimization, autonomic regulation practices, and ongoing trauma-informed psychotherapy. The objective was to address potential upstream contributors to persistent symptoms rather than focusing exclusively on downstream psychiatric manifestations.
A complex case of anxiety, OCD, emotional eating, and hyperandrogenic PCOS explores how early-life adversity may influence stress physiology, metabolic dysfunction, inflammation, and the gut-brain axis through interconnected biological pathways.
For more than half a century, modern psychiatry has made remarkable advances in the classification and treatment of mental illness. Diagnostic criteria contained within the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) have improved diagnostic reliability, while pharmacologic therapies targeting neurotransmitter pathways have transformed the lives of millions of patients living with anxiety, depression, and obsessive-compulsive disorder (OCD). Yet an important question remains largely unanswered: Why do these disorders develop in the first place? Even with evidence-based psychotherapy and appropriately selected medications, many patients continue to experience persistent symptoms, suggesting that neurotransmitter dysfunction alone may not fully explain the biological origins of psychiatric disease.
Over the past three decades, research from neuroscience, endocrinology, immunology, developmental biology, and metabolism has begun to reshape our understanding of how early life experiences influence lifelong health. Adverse childhood experiences (ACEs) have been associated with increased risks of asthma, cardiovascular disease, obesity, autoimmune disorders, type 2 diabetes, substance use disorders, depression, anxiety, and premature mortality. These associations are remarkably consistent across diverse populations and persist even after adjustment for socioeconomic status and other confounding variables.1,2,3,4
Bruce McEwen proposed that chronic activation of stress-response pathways produces allostatic load, the cumulative physiologic cost of repeatedly adapting to adversity.5,6 While these adaptive responses are essential for short-term survival, prolonged activation gradually alters neuroendocrine signaling, immune regulation, autonomic balance, metabolism, and cellular energetics. Increasing evidence suggests that these physiologic adaptations become biologically embedded, leaving measurable changes in multiple organ systems long after the original stressor has resolved.3
One plausible mechanism through which allostatic load becomes biologically embedded is dysregulated immunoneurometabolism, the continuous bidirectional communication among the immune, nervous, endocrine, and metabolic systems that collectively regulate physiologic adaptation to the internal and external environment. These systems are not independent; they function as an integrated network in which changes in one system inevitably influence the others. Chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis influences insulin signaling. Hyperinsulinemia alters reproductive endocrinology. Endocrine dysfunction modifies immune activity and gut microbial ecology. The gut microbiome, in turn, communicates directly with both the immune system and the central nervous system through microbial metabolites, neural pathways, and inflammatory signaling. Rather than existing as isolated physiologic abnormalities, these disturbances often reinforce one another through interconnected feedback loops that may progressively amplify disease.
From an evolutionary perspective, these adaptations are remarkably logical. Throughout most of human history, uncertainty was synonymous with survival. Food scarcity, social instability, infection, environmental danger, and interpersonal violence demanded rapid physiologic adaptation. Increased vigilance, transient insulin resistance, preferential storage of energy, heightened cortisol secretion, and a biologic drive toward calorie-dense foods would all have improved the probability of surviving prolonged adversity. The human organism evolved not to maximize longevity, but to maximize reproductive success under conditions of environmental unpredictability.4.4
The modern environment presents a fundamentally different challenge. Chronic psychological stress now exists alongside continuous access to inexpensive, highly processed foods engineered to activate ancient reward pathways. Behaviors that once promoted survival may now perpetuate obesity, insulin resistance, hyperandrogenism, chronic inflammation, and psychiatric disease. The very physiologic responses that were once adaptive have become maladaptive when activated continuously within an environment for which they were never designed.
This evolutionary framework suggests that psychiatric symptoms may represent more than disorders of neurotransmission alone. They may also reflect downstream manifestations of dysregulated systems biology that originated years earlier through the biological embedding of childhood adversity. If this hypothesis is correct, understanding the upstream physiology that gives rise to downstream behavioral symptoms may expand therapeutic opportunities while complementing, not replacing, evidence-based psychiatric care.
The following case illustrates this systems biology framework in a 19-year-old woman with treatment-resistant anxiety, obsessive-compulsive disorder, emotional eating, and hyperandrogenic polycystic metabolic ovary syndrome (PCMOS). Rather than presenting a single causative abnormality, the case demonstrates how coordinated disturbances across neuroendocrine, metabolic, gastrointestinal, nutritional, and immune physiology may collectively provide a biologic explanation for a persistent psychiatric phenotype. The purpose of this report is not to establish causation from a single patient but to illustrate how the concept of biological embedding may help clinicians move beyond symptom classification toward a more integrated understanding of disease.
Case Presentation
A 19-year-old white female presented with progressive anxiety, obsessive-compulsive behaviors, panic attacks, intermittent dysthymia, and chronic emotional eating despite several months of selective serotonin reuptake inhibitor therapy and ongoing intensive psychotherapy. Although both interventions produced modest improvement, panic attacks remained frequent, intrusive obsessive thoughts persisted, and emotional eating continued to interfere with daily functioning.
Her developmental history was remarkable not for direct physical trauma, but for prolonged household adversity. At approximately nine years of age, her older sister disclosed sexual abuse and subsequently developed severe post-traumatic stress disorder followed by an eating disorder requiring prolonged inpatient treatment. During these years, the patient’s mother spent extended periods away from home caring for the sister, leaving the patient primarily in the care of her father.
Although she was never the direct victim of abuse, the family environment became organized around chronic psychological crisis. Household instability, emotional uncertainty, and prolonged disruption persisted throughout late childhood and early adolescence. During this period, she increasingly relied upon nighttime eating as a mechanism for emotional regulation, eventually developing persistent anxiety, obsessive-compulsive symptoms, panic attacks, intermittent dysthymia, and binge-eating behaviors.
At this point in the evaluation, the central clinical question shifted. Rather than asking, “What psychiatric diagnosis best explains these symptoms?”, a systems biology approach asked a different question:
What upstream physiologic systems became dysregulated over time, and could those interacting systems help explain the downstream behavioral phenotype?
Systems Biology Assessment
The purpose of a systems biology evaluation is not to identify isolated abnormal laboratory values but to determine whether seemingly unrelated physiologic disturbances converge upon a common biologic narrative. Rather than viewing endocrine, gastrointestinal, nutritional, and immune findings as separate problems, this approach asks whether they represent coordinated manifestations of a shared upstream dysregulation.
Inspired by the work of developmental psychologist Mona Delahooke, who encourages clinicians to look “below the waterline” to understand the physiology driving behavior rather than focusing solely on observable symptoms, the objective of this evaluation was to identify the physiologic systems that may have become biologically embedded over time.5.5 From this perspective, behavior is viewed not as the disease itself but as the outward expression of underlying neurobiologic adaptation.
Neuroendocrine System
DUTCH Plus testing demonstrated elevated waking cortisol, persistent elevation of cortisol during the late morning and afternoon, increased cortisol clearance (62%), and elevated metabolized cortisol production. Collectively, this pattern suggested chronic activation of the hypothalamic-pituitary-adrenal (HPA) axis rather than adrenal insufficiency.
Persistent cortisol exposure has been associated with alterations in hippocampal neuroplasticity, impaired executive function, insulin resistance, immune activation, and changes in appetite regulation.7,8,9 While cortisol itself is adaptive during periods of acute stress, prolonged activation of the HPA axis increases allostatic load and may represent one mechanism through which childhood adversity becomes biologically embedded.
Importantly, these findings were interpreted within the context of the patient’s clinical history rather than as independent diagnostic abnormalities. The laboratory profile did not establish causation; rather, it demonstrated physiologic consistency with prolonged activation of stress-response pathways.
“Childhood adversity does not reside exclusively in memory. It may become biologically embedded across neuroendocrine, metabolic, immune, gastrointestinal, and nutritional systems, leaving measurable physiologic fingerprints that shape health for decades.”
Endocrine Metabolic System
The reproductive hormone profile demonstrated markedly reduced estradiol and progesterone with elevated androgen metabolites including a DHEA of 744 ng/dl, a pattern consistent with hyperandrogenic Polycystic Metabolic Ovary Syndrome (PCMOS).
Although traditionally referred to as polycystic ovary syndrome (PCOS), increasing evidence suggests that metabolic dysfunction, particularly insulin resistance and compensatory hyperinsulinemia, lies at the center of the disorder. Throughout this manuscript, the term PCMOS is used to emphasize the metabolic biology underlying the syndrome rather than its ovarian morphology.
Women with PCMOS consistently demonstrate higher rates of anxiety, depression, obsessive-compulsive symptoms, binge eating, and reduced quality of life than women without the disorder.10,11 Hyperinsulinemia stimulates ovarian androgen production, suppresses sex hormone-binding globulin, promotes systemic inflammation, and alters neurosteroid signaling within the central nervous system. These endocrine alterations may amplify psychiatric symptoms while simultaneously reinforcing metabolic dysfunction. 10-14
Rather than representing an isolated gynecologic disorder, PCMOS may therefore function as an important intermediary connecting chronic stress physiology with behavioral health.
Gut Brain Axis
Comprehensive stool analysis demonstrated reduced production of short-chain fatty acids, particularly butyrate, without evidence of intestinal inflammation or enteric infection. Although gastrointestinal symptoms were minimal, these findings suggested impaired microbial fermentation and diminished production of metabolites essential for gut-brain communication.
Butyrate serves as the primary energy substrate for colonocytes while simultaneously regulating intestinal barrier integrity, regulatory T-cell differentiation, mitochondrial function, and neuroimmune signaling.14,15 Experimental evidence further suggests that microbial metabolites influence vagal signaling, microglial activation, blood-brain barrier integrity, and neurotransmitter synthesis, illustrating the increasingly recognized role of the microbiota-gut-brain axis in mental health.14,15
These findings support the possibility that altered microbial metabolism represented another downstream manifestation of chronic physiologic dysregulation rather than an isolated gastrointestinal disorder.
Nutritional Biology
Omega-3 Index measured 2.7%, well below the range generally associated with optimal cardiovascular and neurologic health. Iron storage was noted with a ferritin of 4.5 ng/ml, serum iron of 160 microgm/dl, transferrin 420 mg/dl, TIBC 588 microgm/dl and transferrin saturation 27%. An RDW was at 15.2%
Vitamin D 25OH was 27 which is below the normal healthy range for immune regulatory capacity.
Omega-3 fatty acids are fundamental structural components of neuronal membranes and contribute to synaptic plasticity, membrane fluidity, mitochondrial function, and the production of specialized pro-resolving mediators that actively terminate inflammation. Deficiency has been associated with increased vulnerability to mood disorders and diminished resilience to chronic physiologic stress.16-19
The iron indices paint a picture of iron deficiency at the storage level where warehouses (ferritin) are empty, the delivery trucks (transferrin) are doubled while the packages currently on trucks (serum iron) are still adequate. The elevated RDW is a reflection of inhibited erythropoiesis due to iron insufficiency. Thus, her picture is one of no reserve for biological reactions that require iron sufficiency sustained over time.
A 25 OH vitamin D level of 27 ng/mL isn’t likely the primary driver of immune dysfunction, but it may represent reduced physiologic reserve. If a person is simultaneously dealing with poor nutrition, obesity, insulin resistance, sleep disruption, and chronic stress, that modest vitamin D insufficiency may contribute to tipping the system toward a more pro-inflammatory phenotype. This is especially noted in the context of T regulatory cell function, being diminished. 19.5
Although nutritional deficiencies rarely explain complex psychiatric illness independently, they may substantially influence the adaptive capacity of interconnected physiologic systems already operating under chronic stress.
Immune Metabolic Homeostasis
Although conventional inflammatory biomarkers were unremarkable, assessment of innate immune homeostasis demonstrated a Systemic Immune-Inflammation Index (SII) of greater than 894, a value well above the range typically observed in healthy young adults (Calculated SII = (Absolute neutrophils 4.6 X 428 platelets)/2.2 absolute lymphocytes). Unlike isolated inflammatory biomarkers such as C-reactive protein, the SII integrates neutrophil, lymphocyte, and platelet counts into a composite measure reflecting the dynamic balance between innate inflammatory activation and adaptive immune regulation. Increasing evidence suggests that elevated SII is associated with chronic inflammatory disorders, cardiovascular disease, malignancy, metabolic dysfunction, and a growing number of neuropsychiatric conditions.21
From a systems biology perspective, this finding is particularly relevant because immune activity does not operate independently of the nervous or endocrine systems. Chronic activation of the HPA axis, hyperinsulinemia, alterations in gut microbial metabolites, and nutritional deficiencies each influence immune cell trafficking and inflammatory signaling. Consequently, an elevated SII may represent another downstream manifestation of dysregulated immunoneurometabolism rather than an isolated marker of inflammation.
Importantly, the SII should not be interpreted as evidence of active inflammatory disease in this patient beyond mood disorder and PCMOS. Instead, it contributes another physiologic data point that is biologically coherent with the broader pattern of neuroendocrine, metabolic, gastrointestinal, and nutritional dysregulation identified throughout the evaluation. Viewed collectively, these findings suggest reduced physiologic resilience across multiple interconnected systems rather than pathology confined to a single organ.
Genomic Susceptibility
Genomic analysis identified variants involving inflammatory regulation, oxidative stress, mitochondrial resilience, insulin signaling, neuroplasticity, detoxification pathways, and monoamine metabolism, including APOE3/4, GSTT1 deletion, BDNF, MAOA, MTNR1B, and FTO polymorphisms.
These findings were not interpreted as deterministic causes of disease. Rather, they were considered biologic susceptibilities that may modify an individual’s response to environmental adversity throughout development. The phenotype, not the genotype, remained the primary focus of clinical decision-making.
Taken individually, none of these physiologic systems adequately explained the patient’s clinical presentation. Collectively, however, they revealed a striking convergence of neuroendocrine, metabolic, gastrointestinal, nutritional, and genomic findings that were biologically coherent with the concept of immunoneurometabolic dysregulation following prolonged childhood adversity.
Discussion
One of the greatest challenges in medicine is the tendency to divide human physiology into organ-specific specialties. Endocrinologists study hormones. Psychiatrists study behavior. Gastroenterologists study the intestine. Immunologists study inflammation. Yet the human organism recognizes no such boundaries. These systems evolved together, communicate continuously, and adapt collectively to changes in the internal and external environment.
This patient’s laboratory evaluation did not identify a single explanation for her psychiatric illness. Instead, it revealed convergence across interconnected physiologic systems. That convergence is precisely what might be expected if the underlying disturbance were not a disorder of neurotransmission alone, but a broader dysregulation of immunoneurometabolism.
Early life adversity may initiate chronic activation of the HPA axis, resulting in prolonged cortisol exposure that promotes insulin resistance, alters ovarian steroidogenesis, influences appetite regulation, and modifies immune signaling. Simultaneously, persistent psychological stress often drives emotional eating behaviors. From an evolutionary perspective, seeking calorie-dense foods during periods of uncertainty represents an adaptive survival strategy. In the modern food environment, however, repeated consumption of refined carbohydrates and ultra-processed foods reinforces hyperinsulinemia, promotes hyperandrogenic PCMOS, amplifies systemic inflammation, and further disrupts neuroendocrine regulation. The result is a self-reinforcing cycle in which psychological stress, metabolism, endocrine function, immunity, gastrointestinal physiology, and behavior become increasingly intertwined.
Importantly, this systems biology framework does not argue that laboratory findings replace psychiatric diagnosis, nor does it imply that any single biomarker establishes causation. Instead, it proposes that psychiatric symptoms may represent the downstream clinical expression of multiple interacting physiologic networks whose cumulative dysregulation exceeds the adaptive capacity of the individual.
Treatment: Restoring Physiologic Resilience
The treatment strategy was designed around the hypothesis that the patient’s psychiatric symptoms represented the downstream expression of dysregulated immunoneurometabolic physiology rather than isolated neurotransmitter dysfunction. Consequently, therapeutic interventions focused on restoring physiologic resilience across multiple interconnected systems while continuing evidence-based psychiatric care.
The primary intervention centered on nutrition. Under the guidance of a registered dietitian, the patient adopted an anti-inflammatory dietary pattern emphasizing minimally processed whole foods while substantially reducing refined carbohydrates and ultra-processed foods. The rationale extended beyond weight management. Reducing repeated insulin excursions was intended to improve metabolic flexibility, decrease hyperinsulinemia, reduce androgen production, and lessen inflammatory signaling while simultaneously supporting a healthier gut microbial environment.16,17
Nutritional deficiencies identified during the systems biology evaluation were corrected through targeted supplementation, including omega-3 fatty acids with the goal of restoring the Omega-3 Index into the range associated with improved cardiovascular and neurologic health. Micronutrient replacement was individualized according to laboratory findings, recognizing that optimal cellular function depends upon adequate nutritional substrates.
The patient’s endocrine profile suggested hyperandrogenic PCMOS. Therapeutic strategies therefore emphasized improving insulin sensitivity through nutrition and lifestyle while incorporating targeted nutritional support intended to optimize estrogen metabolism and reduce androgenic burden. Because endocrine physiology is highly responsive to metabolic health, restoration of metabolic flexibility was viewed as the foundational intervention.
Recognizing the importance of the microbiota-gut-brain axis, dietary fiber intake was increased and targeted prebiotic and probiotic therapies were introduced to support short-chain fatty acid production and microbial diversity. These interventions were intended to improve intestinal barrier integrity, neuroimmune communication, and production of beneficial microbial metabolites rather than simply treating gastrointestinal symptoms.
Equally important, the patient continued intensive trauma-informed psychotherapy throughout treatment. If adverse childhood experiences become biologically embedded through chronic activation of stress-response systems, meaningful recovery likely requires addressing both the physiologic adaptations and the experiences that initiated them. Behavioral interventions therefore remained central to treatment rather than adjunctive to it.
Finally, interventions designed to improve autonomic regulation, including vagal nerve stimulation exercises, breath work, sleep optimization, and regular physical activity, were incorporated to enhance parasympathetic tone and restore physiologic flexibility. The objective was not merely symptom reduction but improvement in the adaptive capacity of interconnected physiologic systems.20
Rather than functioning as independent therapies, each intervention targeted a different component of the same biologic network. The treatment strategy therefore reflected the underlying hypothesis of the case: that meaningful clinical improvement would most likely occur by simultaneously improving multiple interacting physiologic systems rather than focusing on any single abnormal laboratory value.
Clinical Implications
This case illustrates a broader principle that extends beyond psychiatry. Modern medicine has achieved extraordinary advances through specialization, yet the biologic systems responsible for health remain fundamentally integrated. Immune signaling influences endocrine physiology. Metabolism alters reproductive hormones. The gut microbiome communicates directly with the brain. Chronic stress reshapes immune function, metabolism, autonomic regulation, and behavior simultaneously.
Accordingly, patients with treatment-resistant anxiety, OCD, depression, or emotional eating may benefit from a broader physiologic assessment that extends beyond symptom classification alone. Such an evaluation may include metabolic health, stress physiology, nutritional status, reproductive endocrinology, gastrointestinal function, lifestyle behaviors, sleep, and the developmental experiences that shaped these systems over time.
Importantly, this approach should complement, not replace, established psychiatric diagnosis and evidence-based treatment. Rather than competing with conventional psychiatry, systems biology seeks to expand the clinical lens through which persistent psychiatric illness is understood.
Conclusion
This case demonstrates the concept of biological embedding in a young woman whose persistent anxiety, obsessive-compulsive disorder, emotional eating, and mood symptoms were accompanied by coordinated disturbances across neuroendocrine, metabolic, gastrointestinal, nutritional, and endocrine physiology.
Whether these physiologic findings represent cause, consequence, compensation, or adaptation cannot be determined from a single patient. Nor should specialty laboratory testing be viewed as establishing mechanistic proof. Instead, this case illustrates how multiple biologic systems may converge in a manner that is consistent with the growing understanding of allostatic load, developmental programming, and immunoneurometabolic regulation.
Perhaps the most important lesson from this case is not that specialty testing identified hidden pathology, but that it revealed the remarkable interconnectedness of human physiology. Childhood adversity does not reside exclusively in memory. It may become biologically embedded across neuroendocrine, metabolic, immune, gastrointestinal, and nutritional systems, leaving measurable physiologic fingerprints that shape health for decades.
Looking beneath the behavioral phenotype to understand the upstream biology does not replace evidence-based psychiatric care, it expands it. Psychiatry has traditionally asked, “What diagnosis explains this patient’s symptoms?” Systems biology asks a complementary question: “What upstream physiologic systems became dysregulated that made this phenotype possible?” These are not competing paradigms. Rather, they represent two perspectives on the same patient, one focused on describing disease and the other on understanding its origins.
Ultimately, the goal of systems biology is not simply to diagnose disease more precisely, but to understand why disease developed in the first place.
References
- Felitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med. 1998;14(4):245-258.
- Shonkoff JP, Boyce WT, McEwen BS. Neuroscience, molecular biology, and the childhood roots of health disparities. JAMA. 2009;301(21):2252-2259.
- Berens AE, Jensen SKG, Nelson CA III. Biological embedding of childhood adversity: from physiological mechanisms to clinical implications. BMC Med. 2017;15:135.
- Danese A, McEwen BS. Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiol Behav.2012;106:29-39.
- Gluckman PD, Hanson MA. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Pediatr Res. 2004.
- McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171-179.
- Delahooke M. Beyond Behaviors. Eau Claire, WI: PESI Publishing; 2019.
- McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med. 1993;153:2093-2101.
- Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression. Nat Rev Neurosci. 2008;9:46-56.
- Miller AH, Raison CL. The role of inflammation in depression. Nat Rev Immunol. 2016;16:22-34.
- Niu L, Gao Q, Xie M, et al. Childhood adversity and HPA-axis activity: systematic review and meta-analysis. Neurosci Biobehav Rev. 2025.
- Cooney LG, Lee I, Sammel MD, et al. Depression and anxiety in women with PCOS. Hum Reprod. 2017.
- Brutocao C, Zaiem F, Alsawas M, et al. Psychiatric disorders in women with PCOS: systematic review and meta-analysis. Endocrine. 2018.
- Lustig RH. Which comes first? The obesity or the insulin? The behavior or the biochemistry? JAMA Pediatr. 2008.
- Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018.
- Cryan JF, O'Riordan KJ, Cowan CSM, et al. The microbiota-gut-brain axis. Physiol Rev. 2019.
- Stilling RM, van de Wouw M, Clarke G, et al. The neuropharmacology of butyrate. Neurochem Int. 2016.
- Sarris J, Logan AC, Akbaraly TN, et al. Nutritional medicine as mainstream in psychiatry. Lancet Psychiatry. 2015.
- Marx W, Moseley G, Berk M, Jacka FN. Nutritional psychiatry. Proc Nutr Soc. 2017.
- Bazinet RP, Layé S. Polyunsaturated fatty acids and brain function. Nat Rev Neurosci. 2014.
- Kelaiditis CF, Gibson EL, Dyall SC. Omega-3 fatty acids and anxiety/depression. PLEFA. 2023.
- Fisher SA, Rahimzadeh M, Brierley C, Gration B, Doree C, Kimber CE, Plaza Cajide A, Lamikanra AA, Roberts DJ. The role of vitamin D in increasing circulating T regulatory cell numbers and modulating T regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: A systematic review. PLoS One. 2019 Sep 24;14(9):e0222313.
- Porges SW. The polyvagal theory: phylogenetic substrates of a social nervous system. Int J Psychophysiol. 2001.
- Cui S, Li J, Liu Y, Yao G, Wu Y, Liu Z, et al. Correlation of systemic immune-inflammation index and moderate/major depression in patients with depressive disorders: a large sample cross-sectional study. Front Psychiatry. 2023;14:1159889.
About the author
Current Issue
Related Article


















